Does serial administration of gadolinium‐based contrast agents affect patient neurological and neuropsychological status? Fourteen‐year follow‐up of patients receiving more than fifty contrast administrations

Eitemau Tebyg

• BMET-06 COMET: A PHASE II RANDOMIZED STUDY OF TTFIELDS VERSUS SUPPORTIVE CARE IN NON-SMALL CELL LUNG CANCER PATIENTS WITH 1-5 BRAIN METASTASES - INITIAL SAFETY RESULTS
  gan: Brozova, Hana, et al.
  Cyhoeddwyd: (2015)
• Agreement between the GAITRite® System and the Wearable Sensor BTS G-Walk® for measurement of gait parameters in healthy adults and Parkinson’s disease patients
  gan: Slávka Vítečková, et al.
  Cyhoeddwyd: (2020-05-01)
• Agreement between the GAITRite(®) System and the Wearable Sensor BTS G-Walk(®) for measurement of gait parameters in healthy adults and Parkinson’s disease patients
  gan: Vítečková, Slávka, et al.
  Cyhoeddwyd: (2020)
• Whole brain apparent diffusion coefficient measurements correlate with survival in glioblastoma patients
  gan: Rulseh, Aaron Michael, et al.
  Cyhoeddwyd: (2019)
• A Serial Dilution Study of Gadolinium-Based MR Imaging Contrast Agents
  gan: Bleicher, A.G., et al.
  Cyhoeddwyd: (2008)